| Sequence | Modified GRF (1-29) with drug affinity complex |
|---|---|
| Form | Lyophilized powder (10 vials) |
| Vial contents | with DAC · 5 mg · 10 vials |
| Purity (current lot) | ≥99% (demo) |
| Lot / batch number | DEMO-CJC129-01 |
| COA test date | 2026-10-14 |
| Testing laboratory | Independent ISO 17025 laboratory (demo) |
| Storage | Store at -20°C, protect from light and moisture |
For research use only
CJC-1295 with DAC 5 mg — Box of 10
Lyophilized powder (10 vials), supplied with a lot-matched Certificate of Analysis. For laboratory research use only.
50 in stock
≥99% (demo) purityLot DEMO-CJC129-01
For laboratory research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic.
Description
CJC-1295 with DAC 5 mg — Box of 10 is Modified GRF (1-29) with drug affinity complex, supplied as lyophilized powder in a sealed vial for in-vitro laboratory research. Supplied as a box of ten identical vials from a single lot.
Every lot is independently tested for purity by RP-HPLC and identity by mass spectrometry. The Certificate of Analysis for the current lot is linked in the Specifications tab and in the COA library.
For laboratory research use only. Not for human or veterinary use.




